Laboratory test variability and model for end-stage liver disease score calculation: Effect on liver allocation and proposal for adjustment

Transplantation

Volumn 83, Issue 7, 2007, Pages 919-924

  Ravaioli, Matteo ^a   Masetti, Michele ^b   Ridolfi, Lorenza ^c   Capelli, Maurizio ^a   Grazi, Gian Luca ^a   Venturoli, Nicola ^c   Di Benedetto, Fabrizio ^b   Bianchi, Francesco Bianco ^a   Cavrini, Giulia ^d   Faenza, Stefano ^a   Begliomini, Bruno ^b   Pinna, Antonio Daniele ^a   Gerunda, Giorgio Enrico ^b   Ballardini, Giorgio ^a,e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c AIRT Interregional Center   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e Ospedale Infermi   (Italy)

Author keywords

Allocation; Dropout; Liver transplantation; MELD; Waiting list

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; END STAGE LIVER DISEASE; EXPERIMENTAL MODEL; FEMALE; HUMAN; LABORATORY TEST; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; TUMOR GROWTH;

ADULT; AREA UNDER CURVE; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; CREATININE; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; LABORATORIES; LIVER DISEASES; LIVER FAILURE, ACUTE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OBSERVER VARIATION; PATIENT DROPOUTS; PATIENT SELECTION; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RESOURCE ALLOCATION; TREATMENT OUTCOME;

EID: 34247562229     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000259251.92398.2a     Document Type: Article

References (23)

1. Freeman RB, Wiesner RH, Harper A, et al. UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851.
2. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127: 61.
3. Wiesner R, Edwards E, Freeman R, et al. United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91.
4. Biggins SW, Rodriguez HJ, Bacchetti P, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41: 32.
5. Sharma P, Balan V, Hernandez JL, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004; 10: 36.
6. Bambha K, Kim WR, Kremers WK, et al. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 2004; 4: 1798.
7. Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl 2004; 10: 621.
8. Olthoff KM, Brown RS Jr, Delmonico FL, et al. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 2004; 10: 6.
9. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646.
10. Giannini E, Botta F, Fumagalli A, et al. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients? Liver Int 2004; 24: 465.
11. Trotter JF, Brimhall B, Arjal R, Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004; 10: 995.
12. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.
13. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997; 3: 628.
14. Ravaioli M, Grazi GL, Ercolani G, et al. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 2004; 78: 1780.
15. Ravaioli M, Ercolani G, Cescon M, et al. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transpl 2004; 10: 1195.
16. Swanson AF, Swartentruber M, Nolen PA, et al. Multicenter Evaluation of the Boehringer Mannheim Compensated, Rate-Blanked Creatinine/Jaffe' application on BM/Hitachi Systems. Adv Clin Diag 1993; 3: 10.
17. Mazzachi BC, Peake MJ, Ehrhardt V. Reference range and method comparison studies for enzymatic and Jaffe creatinine assays in plasma and serum and early morning urine. Clin Lab 2000; 46: 53.
18. Kim WR, Therneau TM, Benson JT, et al. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 2006; 43: 345.
19. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837.
20. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29.
21. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929.
22. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307.
23. Ravaioli M, Grazi GL, Ballardini G, et al. Liver transplantation with the Meld system: a prospective study from a single European center. Am J Transplant 2006; 6: 1572.